100 related articles for article (PubMed ID: 2546501)
1. Ketoconazole inhibits self-induced metabolism of 1,25-dihydroxyvitamin D3 and amplifies 1,25-dihydroxyvitamin D3 receptor up-regulation in rat osteosarcoma cells.
Reinhardt TA; Horst RL
Arch Biochem Biophys; 1989 Aug; 272(2):459-65. PubMed ID: 2546501
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
3. Effect of ketoconazole on metabolism and binding of 1,25-dihydroxyvitamin D-3 by intact rat osteogenic sarcoma cells.
Pols HA; Schilte HP; Visser TJ; Birkenhager JC
Biochim Biophys Acta; 1987 Nov; 931(2):115-9. PubMed ID: 2822140
[TBL] [Abstract][Full Text] [Related]
4. Self-induction of 1,25-dihydroxyvitamin D3 metabolism limits receptor occupancy and target tissue responsiveness.
Reinhardt TA; Horst RL
J Biol Chem; 1989 Sep; 264(27):15917-21. PubMed ID: 2550427
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells.
Pols HA; Birkenhäger JC; Schilte JP; Visser TJ
Biochim Biophys Acta; 1988 Jun; 970(2):122-9. PubMed ID: 2838094
[TBL] [Abstract][Full Text] [Related]
6. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional regulation of the 1,25-dihydroxyvitamin D3 receptor by phorbol ester-activated protein kinase-C in osteoblast-like cells: interaction with adenosine 3',5'-monophosphate-induced up-regulation of the 1,25-dihydroxyvitamin D3 receptor.
van Leeuwen JP; Birkenhäger JC; Buurman CJ; van den Bemd GJ; Bos MP; Pols HA
Endocrinology; 1992 Apr; 130(4):2259-66. PubMed ID: 1312452
[TBL] [Abstract][Full Text] [Related]
8. Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and its 24 epimer.
Reinhardt TA; Ramberg CF; Horst RL
Arch Biochem Biophys; 1989 Aug; 273(1):64-71. PubMed ID: 2547343
[TBL] [Abstract][Full Text] [Related]
9. Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways.
Krishnan AV; Cramer SD; Bringhurst FR; Feldman D
Endocrinology; 1995 Feb; 136(2):705-12. PubMed ID: 7835303
[TBL] [Abstract][Full Text] [Related]
10. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
11. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
12. Identification of the subdomain in the nuclear receptor for the hormonal form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3, vitamin D receptor, that is covalently modified by an affinity labeling reagent.
Swamy N; Kounine M; Ray R
Arch Biochem Biophys; 1997 Dec; 348(1):91-5. PubMed ID: 9390178
[TBL] [Abstract][Full Text] [Related]
13. Association of 1 alpha,25-dihydroxyvitamin D3-occupied vitamin D receptors with cellular membrane acceptance sites.
Kim YS; MacDonald PN; Dedhar S; Hruska KA
Endocrinology; 1996 Sep; 137(9):3649-58. PubMed ID: 8756529
[TBL] [Abstract][Full Text] [Related]
14. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
Liel Y; Kraus S; Levy J; Shany S
Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
Lemay J; Gascon-Barré M
Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
[TBL] [Abstract][Full Text] [Related]
16. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by parathyroid hormone and cAMP-agonists.
van Leeuwen JP; Birkenhäger JC; Vink-van Wijngaarden T; van den Bemd GJ; Pols HA
Biochem Biophys Res Commun; 1992 Jun; 185(3):881-6. PubMed ID: 1320878
[TBL] [Abstract][Full Text] [Related]
17. The 1,25-dihydroxy-vitamin D3 receptor is phosphorylated in response to 1,25-dihydroxy-vitamin D3 and 22-oxacalcitriol in rat osteoblasts, and by casein kinase II, in vitro.
Jurutka PW; Terpening CM; Haussler MR
Biochemistry; 1993 Aug; 32(32):8184-92. PubMed ID: 8394128
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
[TBL] [Abstract][Full Text] [Related]
19. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
Zhao X; Feldman D
Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of the intestinal 1,25-dihydroxyvitamin D receptor during hypervitaminosis D: a comparison between vitamin D2 and vitamin D3.
Beckman MJ; Horst RL; Reinhardt TA; Beitz DC
Biochem Biophys Res Commun; 1990 Jun; 169(3):910-5. PubMed ID: 2163637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
